knowledge -WSS

knowledge

author：focus 2025-09-30 15:15:22 - browse：359

Blood corpuscles in clot — Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. David Gregory & Debbie Marshall/Wellcome Images

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries. The tool is meant only for patients with a severe form of peripheral artery disease, and who have already tried more conservative options.

Dan Rose, CEO of LimFlow, previously told STAT that his mission is to fight the amputation epidemic in the United States, which disproportionately impacts Black patients. Experts cautioned to STAT that expanding screenings to catch the disease early is still the most important measure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Readout Newsletter: BridgeBio, Akero, and human embryo models

WSS

For AI in health care standards, federal regulators join with industry group

$1 billion proposal to grow Boston, Massachusetts biotech

Florida health officials providing scant details on measles cases

Microsoft's Peter Lee: Generative AI could help doctors be more human

Ancient Greek ideas underpin modern concepts of pregnancy

The public health thinking behind the CDC’s new Covid guidance

hotspot

knowledge

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Fetal cell organoids grown from amniotic fluid, study finds

Virginia high school admissions case could be legal follow

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Virginia high school admissions case could be legal follow

Lack of health data on LGBTQ+ people has serious consequences

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The untold story of TV’s first prescription drug ad

Dobbs anniversary: the lost opportunity of abortion as health care

First over

entertainment

A new approach to psychiatric drug development

Pregnant women don't need prenatal multivitamins, study concludes

Harvard's David Sinclair gets blowback over aging

The untold story of TV’s first prescription drug ad

Harvard's David Sinclair gets blowback over aging

State of the Union pitch: Bigger Medicare drug price negotiations

entertainment

knowledge

leisure time

explore